NASSHORN PATRICIA 4
4 · Cue Biopharma, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
NASSHORN PATRICIA
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-15+100,000→ 100,000 totalExercise: $11.24Exp: 2031-12-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in four equal semi-annual installments beginning on June 15, 2022.